TBVI Advocacy & Fundraising
The TuBerculosis Vaccine Initiative (TBVI) Advocacy and Fundraising project aims to advocate and raise funds for a tuberculosis vaccine research & development (R&D) portfolio supported by TBVI.
The 3 year project is made possible by a $3 million grant from the Bill & Melinda Gates Foundation. This allows TBVI to build and sustain an advocacy and communications infrastructure, with the following objectives:
- Mobilize financial resources from governments, foundations and private industry to support the mission of TBVI;
- Increase awareness and support among policy makers and other opinion leaders for TB vaccine research and development;
- Increase the scientific community’s engagement, including non-European researchers, in the development of new tuberculosis vaccines.